[{"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0818-2023", "product_description": "Levofloxacin Injection 500mg/20 mL (25 mg/mL), For Intravenous Infusion, packaged in a) 20mL vials and b) 30 mL vials, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "13 units", "code_info": "Rx #'s:    0398243    0394272      0383374    0396251      0365041      0409704    0406772    0406773    0399065    0384313", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TOBRAMYCIN 1.4% (14MG/ML) OPHTHALMIC\t15 ML  \t3 ML  \t  \t7 ML;  \t  \t  TOBRAMYCIN SOLUTION** 0.3% OPHTHALMIC\t30 MLS  \t  \t5 MLS;  TOBRAMYCIN SULFATE** (25X2ML) 80MG/2ML INJECTABLE\t100 ML  \t150 ML  \t50 MLS;  TOBRAMYCIN/AMPHOTERICIN-B/BUDESONIDE, STERILE 125MG/5MG/0.6MG/5ML NASO-NEB\t70 ML  (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1627-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Basel", "state": "N/A", "country": "Switzerland", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63656", "recalling_firm": "F. Hoffmann-LaRoche Ltd.", "address_1": "Grenzacherstrasse 124", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "No product distributed in the USA.  Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.", "recall_number": "D-105-2013", "product_description": "Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom", "product_quantity": "42010 vials", "reason_for_recall": "Lack of Assurance of Sterility; container closure issues with the bulk batch.", "recall_initiation_date": "20120905", "center_classification_date": "20121221", "termination_date": "20130829", "report_date": "20130102", "code_info": "bulk lot N0019, Expiration Date: 11 2014  Warennummer: 10131968  Chargennummer:NXXXX 2000609D  Finished product Lot N0019B01-N0019B12"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64716", "recalling_firm": "Pallimed Solutions", "address_1": "400 W Cummings Park", "address_2": "", "postal_code": "01801-6519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-869-2013", "product_description": "HCG Chorionic Gonadotropin, compounded by Pallimed Solutions Pharmacy, Woburn, MA", "product_quantity": "261 vials", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130325", "center_classification_date": "20130809", "termination_date": "20130821", "report_date": "20130821", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91243", "recalling_firm": "Atlantic Management Resources Ltd.", "address_1": "39 Harvey Ln", "address_2": "N/A", "postal_code": "01581-3013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0083-2023", "product_description": "ProSirona, A Homeopathic Formula, Calendula Oil packaged in 1/8 Fl. oz. (3.5 g) bottles, Dist. by: Endometriosis Assoc. Inc. (International), Mfg. by Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233-712-01.", "product_quantity": "72 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221212", "center_classification_date": "20221213", "termination_date": "20230920", "report_date": "20221221", "code_info": "Lot Code B-02"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-677-2013", "product_description": "Test Cyp 50 mg-estradiol blend 22 mg, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "13ml total", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCAIBA:36, Exp date: 4/6/2013; Lot number CABDDAAB:10, Exp date: 7/29/2013 and Lot number CABDAIAD:01 Exp date: 9/4/2013."}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-534-2013", "product_description": "CPM / PSE DM Drops, Antihistamine, Cough Suppressant  Decongestant, 1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872 NDC 13811-072-30", "product_quantity": "26,315 - 30 mL bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11EQ007 Exp 04/13; Lot# 12BQ001  Exp. 01/14.."}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1563-2019", "product_description": "DIPPIN' DOTS SCENTED COTTON CANDY ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "13,068", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181213, Exp 12/12/2020"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73671", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0840-2016", "product_description": "Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-3978-93", "product_quantity": "2928 bottles", "reason_for_recall": "Failed Dissolution Specifications; three month stability time point.", "recall_initiation_date": "20160212", "center_classification_date": "20160506", "termination_date": "20161026", "report_date": "20160518", "code_info": "Lot: 2005441, 01/2017, Code: 0378-3978-93"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-633-2015", "product_description": "Diphenylcyclopropenone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77605", "recalling_firm": "Shionogi Inc.", "address_1": "5770 Shiloh Rd", "address_2": "N/A", "postal_code": "30005-8408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0982-2017", "product_description": "PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981", "product_quantity": "455 bottles", "reason_for_recall": "Failed Dissolution Specifications: Low dissolution results were obtained during stability testing", "recall_initiation_date": "20170524", "center_classification_date": "20170714", "termination_date": "20180228", "report_date": "20170726", "code_info": "Lot #: 5H66200103, Exp. June 2018"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0794-2023", "product_description": "Clobetasol Propionate Cream, USP, 0.05%, packaged in a) 15g tubes, b) 30g tubes, and c) 60g tubes, Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0503-2021", "product_description": "Infants Aqueous Vitamin D Oral Drops 400 IU/mL 50 mL (1 2/3 fl oz) Manufactrued by: Silarx Pharmaceuticals, Inc. 19 West Street Spring Valley, NY 10977 USA", "product_quantity": "422 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0040-2023", "product_description": "MOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "106 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 66470, BUD: 11/10/2022"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-954-2013", "product_description": "ESTRADIOL CYP/PROG/TEST CYP 0.5/10/10 MG/ML OIL INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "05012013@25, 06202013@6", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1120-2020", "product_description": "Detoxin-S, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1768-2019", "product_description": "DIPHENHYDRAMINE 25 MG/50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-070-2014", "product_description": "Depo-Testadiiol, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-935-2015", "product_description": "Tolvaptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Detroit", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090142"], "brand_name": ["CETIRIZINE HYDROCHLORIDE"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-343", "47335-344"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014643", "1014674"], "spl_id": ["2ffbb45f-ed2b-4f1a-bc4c-1e8c1ddcbfd3"], "spl_set_id": ["a4758152-97dd-4a27-b4d9-11178654b93e"], "package_ndc": ["47335-343-83", "47335-343-88", "47335-344-83", "47335-344-88"], "is_original_packager": [true], "upc": ["0347335344837", "0347335343830"], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "67971", "recalling_firm": "Caraco Pharmaceutical Laboratories, Ltd.", "address_1": "1150 Elijah McCoy Dr", "address_2": "", "postal_code": "48202-3344", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1296-2014", "product_description": "Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat, India, NDC 47335-343-83", "product_quantity": "128,363 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide", "recall_initiation_date": "20140409", "center_classification_date": "20140501", "termination_date": "20141007", "report_date": "20140507", "code_info": "JKM2067A Exp. 07/14, JKM2068A Exp.10/14, JKM2069A Exp. 01/15, JKM6399A Exp. 04/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-762-2015", "product_description": "Lidocaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "33300 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PERPHENAZINE, Tablet, 8 mg may have potentially been mislabeled as the following drug:  NIFEdipine, Capsule, 10 mg, NDC 59762100401, Pedigree: AD52778_55, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "PERPHENAZINE, Tablet, 8 mg has the following codes:   Pedigree: AD54605_1, EXP: 4/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PERPHENAZINE, Tablet, 8 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00630506221.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-995-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1525-2020", "product_description": "Phentermine 15mg grey/Yellow Capsules, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: Sunrise Pharm., Rahway NJ, 07065; NDC 11534-0157-03", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #:19330; Exp. Date: 12/20"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97183", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0536-2025", "product_description": "Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.", "product_quantity": "2,890 vials", "reason_for_recall": "Sub-Potent Drug: Subpotent assay results during stability testing.", "recall_initiation_date": "20250709", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: 25MAR032, Exp. 07/16/2025."}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97540", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "N/A", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0646-2025", "product_description": "bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226", "product_quantity": "109,320 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250829", "center_classification_date": "20250912", "report_date": "20250924", "code_info": "Lot #: C274-000044756, C274-000044757, Exp 8-30-2025; C274-000044832, C274-000044833, Exp 9-4-2025; C274-000044882, C274-000044883, Exp 9-6-2025, C274-000044972, Exp 9-8-2025; C274-000045004, C274-000045005, Exp 9-18-2025 C274-000045108, exp. date 9-13-2025 C274-000045109, exp. date 9-13-2025 C274-000045136, exp. date 9-14-2025 C274-000045137, exp. date 9-14-2025 C274-000045289, exp. date 9-20-2025 C274-000045290, exp. date 9-20-2025 C274-000045350, exp. date 9-22-2025 C274-000045351, exp. date 9-22-2025 C274-000045387, exp. date 9-25-2025 C274-000045388, exp. date 9-25-2025 C274-000045516, exp. date 9-27-2025 C274-000045517, exp. date 9-27-2025 C274-000045586, exp. date 10-2-2025 C274-000045587, exp. date 10-2-2025 C274-000045676, exp. date 10-4-2025 C274-000045677, exp. date 10-4-2025 C274-000045707, exp. date 10-5-2025 C274-000045708, exp. date 10-5-2025 C274-000045754, exp. date 10-9-2025 C274-000045755, exp. date 10-9-2025 C274-000045840, exp. date 10-11-2025 C274-000045841, exp. date 10-11-2025 C274-000046048, exp. date 10-24-2025 C274-000046049, exp. date 10-24-2025 C274-000046095, exp. date 10-25-2025 C274-000046096, exp. date 10-25-2025 C274-000046122, exp. date 10-26-2025 C274-000046123, exp. date 10-26-2025 C274-000046164, exp. date 10-30-2025 C274-000046165, exp. date 10-30-2025 C274-000046191, exp. date 10-31-2025 C274-000046192, exp. date 10-31-2025 C274-000046240, exp. date 11-1-2025 C274-000046241, exp. date 11-1-2025 C274-000046315, exp. date 11-6-2025 C274-000046316, exp. date 11-6-2025 C274-000046345, exp. date 11-7-2025 C274-000046346, exp. date 11-7-2025 C274-000046515, exp. date 11-14-2025 C274-000046516, exp. date 11-14-2025 C274-000046603, exp. date 11-16-2025 C274-000046657, exp. date 11-20-2025 C274-000047136, exp. date 12-12-2025"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0318-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 40mcg/2mg/60mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "17 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 07282016G (09/08/2016), 07082016E (08/22/2016), 07142016D (08/22/2016)."}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0937-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection  20MCG/30MG/1MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0545-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11112019+53210, Exp 4/4/2020"}, {"status": "Terminated", "city": "Bedford", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62490", "recalling_firm": "Ben Venue Laboratories Inc", "address_1": "300 Northfield Rd", "address_2": "N/A", "postal_code": "44146", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-036-2013", "product_description": "Leucovorin Calcium Injection USP, single use vials, 10mg/mL; 50mL, Rx only, Manufactured by: Ben Venue Labs, Inc., Bedford, OH 44146, NDC# 55390-009-01(Bedford); NDC# 55390-826-01(Novaplus)", "product_quantity": "226,010 vials", "reason_for_recall": "Presence of Particulate Matter: visible crystalline particulates and the discovery of crystalline particulate in a retain sample.", "recall_initiation_date": "20120705", "center_classification_date": "20121101", "termination_date": "20130830", "report_date": "20121107", "code_info": "Lot #, 2017619 (Bedford), Mfr Item # 0967-57-2017619, NDC, 55390-009-01, Exp. Date 11/2012; Lot# 2017620, Exp. Date 1/2013, NDC #55390-009-01; Lot #, 2017621 (Bedford), Mfr Item # 0967-57-2017621, NDC, 55390-009-01, Exp Date 01/2013; Lot #2038374, exp. 2/2013, NDC #55390-009-01; Lot #2038374A, exp. 2/2013, NDC #55390-826-01 Note: 2038374A (packaged using Novaplus labeling) is a sublot of 2038374 (packaged using Bedford labeling); Lot #, 2038375 (Bedford), Mfr Item # 0967-57-2038375, NDC, 55390-009-01, Exp Date 03/2013; Lot #, 2065418 (Bedford), Mfr Item # 0967-57-2065418, NDC, 55390-009-01, Exp Date 06/2013; Lot #, 2067176 (Bedford), Mfr Item # 0967-57-2067176, NDC, 55390-009-01, Exp Date, 06/2013; Lot #, 2067177 (Bedford), Mfr Item # 0967-57-2067177, NDC, 55390-009-01, Exp Date 06/2013 & Lot #, 2067178A (Novaplus), Mfr Item # 0967-57-2067178A, NDC, 55390-826-01, Exp Date, 06/2013.", "more_code_info": ""}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89807", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0714-2022", "product_description": "Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05", "product_quantity": "312 bottles", "reason_for_recall": "Defective Container: Leaking containers.", "recall_initiation_date": "20211207", "center_classification_date": "20220322", "termination_date": "20231005", "report_date": "20220330", "code_info": "Lot #: 24MA2010 Exp. 1/31/2023"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68813", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd., Suite 3", "address_2": "N/A", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1513-2014", "product_description": "buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.", "product_quantity": "840 bottles", "reason_for_recall": "Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.", "recall_initiation_date": "20140714", "center_classification_date": "20140805", "termination_date": "20150112", "report_date": "20140813", "code_info": "Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NIFEDIPINE Capsule, 10 mg may be potentially mislabeled as     MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F), NDC 64376081501, Pedigree: AD22609_7, EXP: 5/2/2014;  NIFEDIPINE, Capsule, 10 mg, NDC 43386044024, Pedigree: AD23082_7, EXP: 9/23/2013.", "address_2": "", "product_quantity": "202 Capsules", "code_info": "NIFEDIPINE, Capsule, 10 mg has the following codes    Pedigree: AD23082_7, EXP: 9/23/2013;  Pedigree: AD23082_10, EXP: 9/23/2013.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NIFEDIPINE Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386044024", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-565-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0438-2025", "product_description": "Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 0.85 OZ (24 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-03", "product_quantity": "616,160 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0014, B0015, B0022, B0023, Exp Date: 05/31/2026; Lot B0024, B0025, B0026, B0027, B0033, B0034, B0035, B0039, B0040, B0041, B0045, Exp Date: 06/30/2026; Lot B0046, Exp Date: 07/31/2026"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020439"], "brand_name": ["BETIMOL"], "generic_name": ["TIMOLOL"], "manufacturer_name": ["Thea Pharma Inc."], "product_ndc": ["82584-001", "82584-002"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL"], "rxcui": ["208560", "1992305", "2702393", "2702398"], "spl_id": ["3891d7f3-d858-9f71-e063-6394a90af95b"], "spl_set_id": ["3ae775f4-340c-4bf4-aa49-8a31daba0f8b"], "package_ndc": ["82584-001-05", "82584-002-05", "82584-002-15"], "is_original_packager": [true], "upc": ["0382584002053"], "unii": ["817W3C6175"]}, "product_type": "Drugs", "event_id": "94146", "recalling_firm": "Thea Pharma, Inc.", "address_1": "303 Wyman St", "address_2": "N/A", "postal_code": "02451-1208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0374-2024", "product_description": "Betimol (timolol ophthalmic solution) 0.5%,  15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15", "product_quantity": "5,476 bottles", "reason_for_recall": "Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.", "recall_initiation_date": "20240305", "center_classification_date": "20240311", "termination_date": "20250630", "report_date": "20240320", "code_info": "Lot #: 435019, Exp. Date 11/2024"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80997", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1209-2018", "product_description": "Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6625-8", "product_quantity": "26217 boxes of 8 patches", "reason_for_recall": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20180907", "center_classification_date": "20180925", "termination_date": "20200909", "report_date": "20181003", "code_info": "Lots: 82199 Exp. 12/2018; 83025 Exp. 05/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0158-2023", "product_description": "Tobramycin Ophthalmic Solution, USP, 0.3%, 5 mL per bottle, Rx Only, Manufactured by:  Akorn, Inc., Lake Forest, IL 60045; Distributed by:  MWI, Boise, ID 83705. NDC 13985-604-05", "product_quantity": "91,692 bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 1D94A, EXP 3/31/2023; 1E35A, EXP 4/30/2023; 2A06A, EXP 12/31/2023"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["UP AND UP CHILDRENS ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Target Corporation"], "product_ndc": ["11673-105"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["9bc7510c-d284-4ca5-8a86-a346f690f3b1"], "spl_set_id": ["9c3ba4dd-f51b-46ce-91b8-8b617c7b78da"], "package_ndc": ["11673-105-26", "11673-105-28"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0601-2022", "product_description": "Acetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle, Distributed by Perrigo, Allegan, MI 49010.  NDC: 11673-105-26", "product_quantity": "4,992 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1CK0998, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76395", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0644-2017", "product_description": "Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0929-40", "product_quantity": "30 bags", "reason_for_recall": "Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.", "recall_initiation_date": "20170203", "center_classification_date": "20170405", "termination_date": "20171019", "report_date": "20170412", "code_info": "Lot: 20161222@8, Exp 2/5/2017"}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["GABA 300-EZS"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["PureTek Corporation"], "product_ndc": ["59088-725"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["310431"], "spl_id": ["b43e4780-f902-89d9-e053-2a95a90a6792"], "spl_set_id": ["bb29692e-1546-4d05-a46a-93baf4172c7d"], "package_ndc": ["59088-725-00", "45963-556-11"], "is_original_packager": [true], "upc": ["0731477272217"]}, "product_type": "Drugs", "event_id": "70001", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0337-2015", "product_description": "Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA, NDC 45963-556-11", "product_quantity": "24,240 Bottles", "reason_for_recall": "Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.", "recall_initiation_date": "20141215", "center_classification_date": "20150108", "termination_date": "20151120", "report_date": "20150114", "code_info": "Lot #s: G01960A1, Exp 09/2015, G01967A1, Exp 10/2015", "more_code_info": ""}, {"country": "United States", "city": "Radnor", "address_1": "259 N Radnor Chester Rd", "reason_for_recall": "Labeling: Not Elsewhere Classified; Due to an error in the manufacturing procedure, a cylinder in liquid withdrawal service was not marked \u001cSyphon Tube\u001d indicating liquid withdrawal and shipped as a gas withdrawal cylinder.", "address_2": "St # 100", "product_quantity": "264 cylinders", "code_info": "NDC 11054-002 Lot # TY00A260A  Size G and H        Part number 835148", "center_classification_date": "20131213", "distribution_pattern": "Kansas, Missouri, and Arkansas.", "state": "PA", "product_description": "Carbon Dioxide, USP, Medical Gas, Rx only, Non Flammable Gas 2, in 50 lbs steel cylinders, Distributed by AIRGAS USA, LLC Radnor, PA", "report_date": "20131225", "classification": "Class II", "openfda": {}, "recalling_firm": "Airgas Medical Services", "recall_number": "D-366-2014", "initial_firm_notification": "Visit", "product_type": "Drugs", "event_id": "66929", "termination_date": "20140626", "recall_initiation_date": "20131106", "postal_code": "19087-5240", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B5014 Exp 8/14/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Diclazuril 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-722-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA208216"], "brand_name": ["AZACITIDINE"], "generic_name": ["AZACITIDINE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-313"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["AZACITIDINE"], "rxcui": ["485246"], "spl_id": ["36080e4e-a0fe-ba15-e063-6394a90aed5c"], "spl_set_id": ["5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a"], "package_ndc": ["68001-313-56"], "is_original_packager": [true], "upc": ["0368001313568"], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["M801H13NRU"]}, "product_type": "Drugs", "event_id": "90594", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Ohio", "recall_number": "D-1334-2022", "product_description": "Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56", "product_quantity": "4162 cartons", "reason_for_recall": "Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.", "recall_initiation_date": "20220722", "center_classification_date": "20220811", "termination_date": "20230412", "report_date": "20220817", "code_info": "Lot: FE22001A, Exp 01/2024", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0323-2023", "product_description": "VANCOMYCIN (a)700 MG NS 140ML, (b) 1000MG IN NS 200ML, abtibiotic, Rx only, use with home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "18 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 28-31, 2022"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89803", "recalling_firm": "Vitae Enim Vitae Scientific, Inc.", "address_1": "3030 Bunker Hill St Ste 203", "address_2": "", "postal_code": "92109-5754", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0741-2022", "product_description": "TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vials per box, Rx only, Manufactured for Cameron Pharmaceuticals, LLC., NDC 42494-437-10.", "product_quantity": "722 boxes", "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20220314", "center_classification_date": "20220405", "termination_date": "20240815", "report_date": "20220413", "code_info": "Lot #: 21VTHI017, 21VTHI018, 21VTHI019, Exp 5/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-492-2015", "product_description": "4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1310 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92857", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "N/A", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1100-2023", "product_description": "activator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% in diluted Activator Solution, Net 1 FL. OZ., Manufactured for: All USA Direct, LLC, Broadview, IL 60155.", "product_quantity": "32,583 bottles", "reason_for_recall": "CGMP Deviations: Products not manufactured under current good manufacturing practices.", "recall_initiation_date": "20230809", "center_classification_date": "20230824", "report_date": "20230830", "code_info": "Lot: 1E175B, exp 6/24"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75628", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0152-2017", "product_description": "Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by Versapharm Inc., An Akorn Company, Lake Forest, IL, Manufactured by Hi-Tech, Pharmacal Co, Inc., Amityville, NY", "product_quantity": "a) 62 tubes  and b) 91 tubes", "reason_for_recall": "Failed Stability Specifications; out-of specification value for homogeneity / phase separation.", "recall_initiation_date": "20161114", "center_classification_date": "20161123", "termination_date": "20190510", "report_date": "20161130", "code_info": "Lot #348716 (exp. 12/2017)"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62887", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1669-2012", "product_description": "METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, This cup delivers 10 mL, Rx Only, Manufactured by VistaPharm, Inc., Largo FL33771", "product_quantity": "73,800 cups", "reason_for_recall": "Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed \"5 mL x 50,\" instead of \"10 mL x 50,\"", "recall_initiation_date": "20110119", "center_classification_date": "20120829", "termination_date": "20120830", "report_date": "20120905", "code_info": "195900  exp. 01/12."}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0750-2016", "product_description": "Hydromorphone HCL 25 mg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Broken Arrow", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72854", "recalling_firm": "Freedom Pharmaceuticals Inc", "address_1": "801 W New Orleans St", "address_2": "N/A", "postal_code": "74011-1844", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0573-2016", "product_description": "Baclofen USP powder, packaged in  (a)  25gm (4 oz container), (b) 100gm (16 oz container), (c) 500 gm (70 oz container), and (d) 1000 gm (120 oz container, Rx only, 801 W New Orleans St. Broken Arrow, OK 74011. NDC: (a) 52372-0909-25; (b) 52372-0909-01; (c) 52372-0909-50; (d) 52372-0909-10.", "product_quantity": "(a) 6 containers, (b) 42 containers, (c) 31 containers, (d) 253 containers", "reason_for_recall": "Presence of Foreign Substance", "recall_initiation_date": "20151109", "center_classification_date": "20160119", "termination_date": "20161223", "report_date": "20160127", "code_info": "Lot #: F10918, F10918-2, Exp: 07/24/2016; F10867, F10867A, Exp date: 03/11/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-953-2015", "product_description": "Vidarbine Monophosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "70", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Norepinephrine Bitartrate 8mg Added to 5% Dextrose 250 mL bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0806-02", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1303-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-661-2015", "product_description": "Ethinyl Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "146 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83698", "recalling_firm": "West-Ward Columbus Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1863-2019", "product_description": "Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59", "product_quantity": "32,347 bottles", "reason_for_recall": "Failed Impurities/Degradation Specificattion", "recall_initiation_date": "20190909", "center_classification_date": "20190916", "termination_date": "20220615", "report_date": "20190925", "code_info": "Lot, expiry:  Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82523", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1074-2019", "product_description": "Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD  21801; NDC 59746-284-90.", "product_quantity": "12,960 bottles", "reason_for_recall": "Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.", "recall_initiation_date": "20190329", "center_classification_date": "20190401", "termination_date": "20190920", "report_date": "20190410", "code_info": "Lot #: PA217060A, Exp 05/2020"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076001"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["50111-647", "50111-648"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["310384", "310385"], "spl_id": ["424ed364-e023-472f-b113-673e9342a7f1"], "spl_set_id": ["06d71a33-5578-4012-b11d-764f45bc1e6a"], "package_ndc": ["50111-647-01", "50111-647-02", "50111-647-03", "50111-648-01", "50111-648-02", "50111-648-03", "50111-648-44"], "is_original_packager": [true], "unii": ["I9W7N6B1KJ"]}, "product_type": "Drugs", "event_id": "70976", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0971-2015", "product_description": "Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.", "recall_initiation_date": "20150413", "center_classification_date": "20150427", "termination_date": "20161027", "report_date": "20150506", "code_info": "Lot #: a) 6A208123, Exp 8/2015; b) 6A208121, Exp  8/2015.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0607-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Headache Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955515326, NDC 57955-5153-2", "product_quantity": "1046 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 020718B Exp. 02/20; 091616M Exp. 09/19"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0401-2021", "product_description": "NIACIN 250MG 110; NDC/UPC 740985228494; OTC; TABLETS", "product_quantity": "4 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"country": "United States", "city": "Shenandoah", "address_1": "604 W Thomas Ave", "reason_for_recall": "Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.", "address_2": "", "product_quantity": "1,913,236 tablets", "code_info": "HD17811", "center_classification_date": "20120622", "distribution_pattern": "Nationwide", "state": "IA", "product_description": "Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, Iowa 51601.", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Lloyd Inc", "recall_number": "D-1395-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61252", "termination_date": "20130730", "more_code_info": "", "recall_initiation_date": "20120224", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "1 Bag", "code_info": "Compounded on 05/30/15, Discard After: 06/13/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Morphine Sulfate, MORPHINE SULFATE 1000mg / NS 100mL, Qty: 1 50 mL Bag, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1200-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "CGMP Deviations", "address_2": "", "product_quantity": "1,299 bags", "code_info": "All lots within Expiry. Lot # 4720915, 6790315, 6800315, 6810315, 6820315", "center_classification_date": "20160907", "distribution_pattern": "Nationwide and Puerto Rico", "state": "PA", "product_description": "ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton).", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva North America", "recall_number": "D-1494-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74497", "termination_date": "20170207", "more_code_info": "", "recall_initiation_date": "20160617", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95650", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "N/A", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0038-2025", "product_description": "Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.", "product_quantity": "6048 pumps", "reason_for_recall": "Crystallization", "recall_initiation_date": "20241029", "center_classification_date": "20241105", "report_date": "20241113", "code_info": "Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205457"], "brand_name": ["BUDESONIDE"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["51407-824"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUDESONIDE"], "rxcui": ["1366550"], "spl_id": ["3c30555b-3552-37a3-e063-6294a90abc68"], "spl_set_id": ["04532cd4-cc79-ef53-e063-6394a90a90ae"], "package_ndc": ["51407-824-30", "5140782430"], "original_packager_product_ndc": ["0591-2510"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "93827", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Illinois only", "recall_number": "D-0276-2024", "product_description": "Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30", "product_quantity": "108 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240112", "center_classification_date": "20240129", "termination_date": "20250320", "report_date": "20240207", "code_info": "Lot #: GS054862, Exp. Date 07/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Farmingdale", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89186", "recalling_firm": "Valisa MFG LLC", "address_1": "131 Executive Blvd", "address_2": "", "postal_code": "11735-4719", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0363-2022", "product_description": "kleantouch HAND SANITIZER (ethyl alcohol 70%), 8.0 FL OZ (236 ML), pump bottles, Distributed by: Valisa MFG, LLC, Farmingdale, NY, 11735, Made in USA, UPC 6 86162 99246 1", "product_quantity": "7704 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol", "recall_initiation_date": "20211206", "center_classification_date": "20220110", "termination_date": "20240226", "report_date": "20220105", "code_info": "Lot #: 1260-1, 1260-2, 1260-3, 1260-4. Exp. 04/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0643-2020", "product_description": "Glenmark Ranitidine Tablets USP 300 mg Rx Only 250 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-249-20", "product_quantity": "500,960 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701069A  7701070A  7701084A  7701085A  7701087A  7701094A  7701095A  7701140A  7701141A  7701142A  7701157A  7701162A  7701182A  7701217A  7701218A  7701219A  7701236A  7701237A  7701220A  7701456A  7701470A  7701520A  7701671A  7701696A  7701697A  7701698A  7701797A  7701928A  7701929A  7701942A  7701943A  7702065A  7702066A  7702067A  7702095A  7702096A  7702097A  7702098A  7702188A  7702189A  7702190A  7702196A  7702197A  7702198A  7702199A  7702348A  7702338A  7702347A  7702349A  7702350A  7702391A  7702392A  7702546A  7702547A  7702548A  7702616A  7702617A  7702618A  7702619A  7702620A  7702763A  7702764A  7702851A  7702852A  7702853A  7702854A  7702855A  7702868A  7702869A  7702870A  7702871A  7702920A  7703054A  7703055A  7703056A  7703057A  7703058A  7703206A  7703208A  7703454A  7703455A  7703456A  7703486A  7703487A  7703488A  7703489A  7703490A  7703945A  7703946A  7703947A  7704111A  7704112A  7704113A  7704234A  7704235A  7704236A  7704237A  7704285A  7704286A  7704287A  7704288A  7704370A  7704371A  7704428A  7704429A  7704430A  7704431A  7704814A  7704838A  7704839A  7704840A  7704935A  7704936A  7704992A  7704996A  7704997A  7704998A  7704999A  7705037A  7705298A  7705299A  7705300A  7705301A  7705302A  7705303A  7705546A  7705584A  7705544A  7705545A  7705572A  7705585A  19190456  19190472  19190490  19191934  19191942  19191959  19192504"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0776-2019", "product_description": "Dr. King's SafeCare Rx CS-Breast, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955021421, NDC 57955-0214-2", "product_quantity": "98 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 091515A Exp. 09/18; 010517B Exp. 01/20"}, {"status": "Terminated", "city": "Visalia", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88409", "recalling_firm": "Je Dois Lavoir LLC", "address_1": "3936 E Evergreen Ave", "address_2": "N/A", "postal_code": "93292-1281", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Sold online via website nationwide in the USA and Canada.", "recall_number": "D-0631-2022", "product_description": "365 SKINNY High Intensity Capsules, 600 mg,  30-count bottle, BODY BALANCE INTERNACIONAL", "product_quantity": "783 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.", "recall_initiation_date": "20210802", "center_classification_date": "20220223", "termination_date": "20230502", "report_date": "20220223", "code_info": "Lot 102-26, Exp Dec 2022"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92657", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "N/A", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0931-2023", "product_description": "Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY  12903, NDC 70324-552-01.", "product_quantity": "132,299 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230707", "center_classification_date": "20230719", "termination_date": "20240708", "report_date": "20230726", "code_info": "Lot #: 490062, Exp 22-Jul-23; 490151, Exp 28-Jul-23; 490732, Exp 6-Aug-23; 491591, Exp 17-Aug-23; 491604, Exp 18-Aug-23; 494418, Exp 16-Nov-23; 494426, Exp 17-Nov-23; 494434, Exp 23-Nov-23; 496755, Exp 25-Nov-23; 497424, Exp 3-Dec-23; 497432, Exp 4-Dec-23; 497441, 497459, Exp 7-Dec-23; 498005, Exp 10-Dec-23; 499075, Exp 22-Jan-24; 499083, 499091, Exp 25-Jan-24; 499391, Exp 26-Jan-24; 501964, Exp 23-Mar-24; 501972, Exp 28-Mar-24; 501981, Exp 30-Mar-24; 501999, Exp 6-Apr-24; 502001, Exp 7-Apr-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0820-2023", "product_description": "Levofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-946-2015", "product_description": "Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "55 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04162015@25, 6/15/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,250 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1523-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075356"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0083", "60505-0097", "60505-0084", "60505-0101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["9cde2ef4-fd50-ed21-0628-cb6cd8a6153f"], "spl_set_id": ["08320ea3-8f93-6f04-5d1c-f69af3eb5a81"], "package_ndc": ["60505-0097-1", "60505-0097-9", "60505-0097-2", "60505-0097-4", "60505-0097-7", "60505-0097-5", "60505-0083-1", "60505-0083-9", "60505-0083-2", "60505-0083-4", "60505-0083-0", "60505-0083-5", "60505-0084-1", "60505-0084-9", "60505-0084-2", "60505-0084-4", "60505-0084-5", "60505-0101-1", "60505-0101-9", "60505-0101-2", "60505-0101-4", "60505-0101-5", "60505-0101-7"], "is_original_packager": [true], "upc": ["0360505010110", "0360505008414", "0360505009718", "0360505008315"], "unii": ["3I3T11UD2S"]}, "product_type": "Drugs", "event_id": "93353", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0121-2024", "product_description": "Paroxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-count bottle, NDC#:60505-0084-2, c)1000-count bottle, NDC#: 60505-0084-4, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.", "product_quantity": "25,776", "reason_for_recall": "Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine", "recall_initiation_date": "20231101", "center_classification_date": "20231127", "report_date": "20231206", "code_info": "Lot numbers: a)100 count bottle: RV8686; b) 1000 count bottle: RX0119; c) 30 count bottle: RV2254; Exp. 08/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0160-2019", "product_description": "HCG Lyopholized 1200 IU Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1743-12", "product_quantity": "881 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04092018:58 Discard by: 10/6/2018; 06072018:03 Discard by: 12/4/2018; 05292018:86 Discard by: 11/25/2018; 07192018:64 Discard by: 1/15/2019; 08302018:30 Discard by: 2/26/2019"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1514-2020", "product_description": "Hydrochlorothiazide 25mg tablets, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Mfg: Accord Healthcare, Inc, Durham, NC 27703, NDC 16729-0183-17", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #: 19355; Exp. Date: 3/21"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0391580", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LISSAMINE GREEN SOLUTION 1% OPHTHALMIC\t10 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1564-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1099-2022", "product_description": "Thrombin JMI, Vial 5,000IU 2/diluent, kit, Rx only, MFG: Pfizer   NDC 60793-215-05", "product_quantity": "157 kits", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0042-2018", "product_description": "Oxytocin 30 units added to 1000 mL 5% Dextrose/Lactated Ringer's USP in 1000 mL bag, Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130 Sugar Land, TX 77478,  NDC# 71019-242-02", "product_quantity": "534 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.", "address_2": "", "product_quantity": "73,746 bottles", "code_info": "Lot #s: L030F11A, L054F11A, Exp 05/13; L095E10A, Exp 06/13; L079J10A, L085K11A, L086K11A, L087G10A, L087K11A, L088K11A, Exp 10/13; L094L10A, Exp 12/13; and L100L10B, Exp 01/14", "center_classification_date": "20120713", "distribution_pattern": "Nationwide", "state": "AL", "product_description": "HYDROXYZINE HYDROCHLORIDE ORAL SOLUTION, USP, 10 mg/5 mL, 1 PINT (473 mL) bottle, Rx only, Mfg. for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-1310-58, UPC 3 0603-1310-58 4.", "report_date": "20120725", "classification": "Class III", "openfda": {}, "recalling_firm": "Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals", "recall_number": "D-1417-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62495", "termination_date": "20131209", "more_code_info": "", "recall_initiation_date": "20120706", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "44 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03122015@93, 6/10/2015; 04242015@46, 7/23/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 30 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1549-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0332-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b) 500-count bottles (NDC 0378-6325-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "32,284 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers:    3084860  3084861    3084862    3093804    3084862    3084863"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76395", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0641-2017", "product_description": "Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0923-59", "product_quantity": "716 bags", "reason_for_recall": "Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.", "recall_initiation_date": "20170203", "center_classification_date": "20170405", "termination_date": "20171019", "report_date": "20170412", "code_info": "Lot: 20161213@23, Exp 2/11/2017; Lot: 20161214@80, Exp 2/12/2017; Lot: 20161215@1, Exp 2/13/2017"}, {"status": "Ongoing", "city": "La Mesa", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94714", "recalling_firm": "MexHealth LLC", "address_1": "4628 Denwood Rd", "address_2": "N/A", "postal_code": "91942-8803", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0558-2024", "product_description": "OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets, packaged in a 30-count bottle, DISTRIBUIDOR POR: Naturistas Especializados, Alce Blanco 180-A Fracc. Industrial, Edo. de Mexico C.P. 53370", "product_quantity": "20 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,", "recall_initiation_date": "20240522", "center_classification_date": "20240617", "report_date": "20240626", "code_info": "Lot Number: H29585, No Expiration date"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020983"], "brand_name": ["VENTOLIN"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0682"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["801092", "801095", "859088", "2123076"], "spl_id": ["cce067df-7227-44ec-9bad-494bce12db01"], "spl_set_id": ["d92c5d6b-ff10-4087-36a2-1cfc464cb967"], "package_ndc": ["0173-0682-20", "0173-0682-24"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "62799", "recalling_firm": "GlaxoSmithKline Inc", "address_1": "1011 North Arendell Ave", "address_2": "P.O. Box 1217", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1666-2012", "product_description": "Ventolin HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 Metered Inhalations,  FOR ORAL INHALATION ONLY - For use with Ventolin HFA actuator only.  Net. wt. 18 g Rx only,  GlaxoSmithKline, Reasearch Triangle Park, NC 27709 NDC 0173-0682-20", "product_quantity": "1,412,566 inhalers", "reason_for_recall": "Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.", "recall_initiation_date": "20120726", "center_classification_date": "20120828", "termination_date": "20140904", "report_date": "20120905", "code_info": "Lot 1ZP7355 Exp. 01/13, 1ZP7749 Exp. 01/13, 1ZP8141 Exp. 01/13, 1ZP8147 Exp. 01/13, 1ZP7729 Exp. 01/13, 1ZP0414 Exp. 03/13, 1ZP0464 Exp. 03/13, 1ZP0570 Exp. 03/13, 1ZP0576 Exp. 03/13, 1ZP0919 Exp. 03/13, 2ZP4959 Exp. 04/13, 2ZP4966 Exp. 04/13"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040765"], "brand_name": ["EXTENDED PHENYTOIN SODIUM"], "generic_name": ["PHENYTOIN SODIUM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENYTOIN SODIUM"], "rxcui": ["855671"], "spl_id": ["2b4f7d43-b5df-46e4-9cb9-216b70a360a0"], "spl_set_id": ["7e467c02-49a0-4b62-b537-430fdfa4f10e"], "package_ndc": ["65162-212-03", "65162-212-10", "65162-212-50", "65162-212-11"], "is_original_packager": [true], "upc": ["0365162212037", "0365162212105"], "unii": ["4182431BJH"]}, "product_type": "Drugs", "event_id": "92368", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "LA, PA and OH.", "recall_number": "D-0876-2023", "product_description": "Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10.", "product_quantity": "9,056 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)", "recall_initiation_date": "20230530", "center_classification_date": "20230615", "termination_date": "20250610", "report_date": "20230621", "code_info": "Lot # HL00721A, Exp. 12/2023"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1550-2019", "product_description": "TOOTSIE ROLL FRUIT CHEWS LIME SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "8,856", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181114, Exp 11/13/2020"}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "53 bottles", "code_info": "Lot K111717A", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Native Remedies VaricoGo Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-105-59", "report_date": "20181114", "classification": "Class I", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0253-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA019117"], "brand_name": ["FLUOCINONIDE"], "generic_name": ["FLUOCINONIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-1253", "51672-1254", "51672-1279", "51672-1264"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINONIDE"], "spl_id": ["3ff6447e-c0b5-e66f-e063-6394a90a311a"], "spl_set_id": ["b0bc89a9-c9d5-4adb-9785-2d4487c4c656"], "package_ndc": ["51672-1253-1", "51672-1253-2", "51672-1253-3", "51672-1253-4", "51672-1254-1", "51672-1254-2", "51672-1254-3", "51672-1279-1", "51672-1279-2", "51672-1279-3", "51672-1264-1", "51672-1264-2", "51672-1264-3"], "is_original_packager": [true], "upc": ["0351672126414", "0351672127923"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["2W4A77YPAN"]}, "product_type": "Drugs", "event_id": "76837", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0790-2017", "product_description": "Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532,  NDC 51672-1254-3", "product_quantity": "7,776 tubes", "reason_for_recall": "Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.", "recall_initiation_date": "20170317", "center_classification_date": "20170518", "termination_date": "20210824", "report_date": "20170524", "code_info": "Lot #: D301311473, D301411473, Exp 3/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0200-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/20 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1366-02", "product_quantity": "815 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03292018:70 Discard by: 9/25/2018; 05302018:94 Discard by: 11/26/2018; 06072018:67 Discard by: 12/4/2018; 06122018:72 Discard by: 12/9/2018; 07252018:72 Discard by: 1/21/2019"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1132-2020", "product_description": "Herpes-G, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66099", "recalling_firm": "JCB Labs LLC", "address_1": "7335 W 33rd St N", "address_2": "N/A", "postal_code": "67205-9368", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Guam", "recall_number": "D-1047-2013", "product_description": "Epinephrine 1:1,000 (1mg/mL) Sterile Solution for injection, Preservative Free/Sulfite Free, 1-mL Single-Use Syringe, Sterile Solution For Office Use Only, JCB Laboratories, Wichita, KS.", "product_quantity": "1243 Syringes", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140818", "report_date": "20130925", "code_info": "Lot # 130806@2, Expiry 09/20/2013.", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83267", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States, PR, and Guam", "recall_number": "D-1487-2019", "product_description": "Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA,  NDC 0409-2776-23, Barcode (01)00304092776233.", "product_quantity": "280340 bags", "reason_for_recall": "Lack of Assurance of Sterility: Bags have the potential to leak.", "recall_initiation_date": "20190709", "center_classification_date": "20190712", "termination_date": "20211027", "report_date": "20190724", "code_info": "Lot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0220-2023", "product_description": "METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/METHYLCOBAL 15MG/50MG/100MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/RIBOFLA/NIACINAMIDE/PYRIDOX/ASCORBIC ACID 15.625MG/31.25MG/31.25MG/6.25MG/62.5MG/6.25MG/62.5MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221011@25 t20221025@48 t20221115@36", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "43 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  02232015@19, 5/24/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 60 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1612-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0004-2020", "product_description": "C-ALBUMIN 5% OPHTH SOLUTION, 10 mL droptainer bottles, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 droptainer bottle", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 071819E, BUD 09/01/19"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0782-2018", "product_description": "Gleevec 100 mg tablet NDC 00078-0401-34 30 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74949", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "666 Plainsboro Rd Ste 210", "address_2": "N/A", "postal_code": "08536-3004", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA", "recall_number": "D-1499-2016", "product_description": "Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90", "product_quantity": "23016 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.", "recall_initiation_date": "20160803", "center_classification_date": "20160914", "termination_date": "20180608", "report_date": "20160921", "code_info": "PSSB16011-A, Exp 01/18", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B3411 Exp 8/11/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Ketamine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-745-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-884-2015", "product_description": "Roflumilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "10 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BN200952"], "brand_name": ["HEXTEND"], "generic_name": ["HETASTARCH"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HETASTARCH"], "rxcui": ["310757", "404665"], "spl_id": ["e72c78a5-62ca-42c8-ace7-d70be50aad36"], "spl_set_id": ["fc79700c-6c3b-4998-8307-4dc8c81c5041"], "package_ndc": ["0409-1555-64", "0409-1555-54"], "is_original_packager": [true], "nui": ["N0000184175", "N0000009361", "N0000010288", "M0020435"], "pharm_class_epc": ["Plasma Volume Expander [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_cs": ["Starch [CS]"], "unii": ["875Y4127EA"]}, "product_type": "Drugs", "event_id": "63522", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-184-2013", "product_description": "HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045,  NDC 0409-1555-54", "product_quantity": "11,412 bags", "reason_for_recall": "Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.", "recall_initiation_date": "20121022", "center_classification_date": "20130305", "termination_date": "20150331", "report_date": "20130313", "code_info": "Lot # 10-199-JT Exp. 10/13"}, {"status": "Ongoing", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93594", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 1 distributor and may have further distributed the product to  repacker/relabelers and pharmacies  in the United States and Canada to be used for prescription compounding.", "recall_number": "D-0154-2024", "product_description": "NYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding,  Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-5 Bar code 3 51552 00415 3", "product_quantity": "13 containers", "reason_for_recall": "Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.", "recall_initiation_date": "20231211", "center_classification_date": "20231221", "report_date": "20231227", "code_info": "Lot#: 230308-U46196, Exp. date 04/30/2025"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87076", "recalling_firm": "Complete Pharmacy and Medical Solutions, LLC.", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0237-2021", "product_description": "HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035", "product_quantity": "2400 vials", "reason_for_recall": "CGMP deviations: Lack of potency testing.", "recall_initiation_date": "20201120", "center_classification_date": "20210119", "termination_date": "20220928", "report_date": "20210127", "code_info": "Lot #: 40548, Use By Date, 01/30/2021.", "more_code_info": ""}]